- Tech X Industry Focus
- Our Technology Clusters
- Biomedical Technology Cluster
- CLINICAL TRANSLATIONAL CATALYST (CTC)
The overarching aim of the Clinical Translational Catalyst (CTC) is to provide a platform to transform Hong Kong and Greater Bay Area to become the go-to destination for translational medicine in the region. Under this programme, funding support will be provided to biomedical companies of HKSTP to bring innovative, life-changing therapies and technologies to patient. In addition, a professional network of key stakeholders such as Principal Investigators from teaching hospitals, clinical trial units, academia and investors will be engaged to work together to turn research into practical products for patients.
If your company has a highly promising project at the pre-clinical/clinical stage, the CTC will work with you to catalyse its development towards attaining regulatory approvals for clinical trials, conducting clinical trials and achieving commercialisation.
Professional & Network Support
Financial Support for Regulatory Affairs
Financial Support for Clinical Trials
This highly selective programme is designed to catalyse the translation of novel and breakthrough technologies and therapies from pre-clinical to the clinical stage. You are eligible to apply for CTC if:
* Companies which are not HKSTP tenants should first apply for tenancy